Wolf-Georg Forssmann

Short-Term Monotherapy in HIV-Infected Patients with a Virus Entry Inhibitor Against the gp41 Fusion Peptide

Uwe Albrecht, Frank Kirchhoff, Jan Münch, 2010, Science Translational Medicine.

Discovery and Optimization of a Natural HIV-1 Entry Inhibitor Targeting the gp41 Fusion Peptide

Shibo Jiang, Thomas Peters, Bernd Meyer, 2007, Cell.

Diversity of human insulin-like growth factor (IGF) binding protein-2 fragments in plasma: primary structure, IGF-binding properties, and disulfide bonding pattern.

Thomas Braulke, T. Braulke, W. Forssmann, 2005, Biochemistry.

Identification of a novel, multifunctional β-defensin (human β-defensin 3) with specific antimicrobial activity

Rainer Hedrich, Sandra Schulz, Claus Vogelmeier, 2001, Cell and Tissue Research.

LEAP‐1, a novel highly disulfide‐bonded human peptide, exhibits antimicrobial activity

Peter Schulz-Knappe, P. Schulz-Knappe, W. Forssmann, 2000, FEBS letters.

Exploiting natural peptide diversity: novel research tools and drug leads.

W. Forssmann, Wolf-Georg Forssmann, Knut Adermann, 2004, Current opinion in biotechnology.